Mutations in both of these proteins are associated with a variety of blinding retinal diseases including retinitis pigmentosa (RP-rhodopsin and RDS), congenital stationary night blindness (CSNB-rhodopsin), and various forms of macular dystrophy (MD-RDS) [1], [2]. Here, PRPH2 is linked to retinitis pigmentosa 1.